Hyperprogressive disease during nivolumab chemotherapy in metastatic gastric cancer: Multicenter retrospective study in Japan.

Takeshi Suzuki,Masahiko Aoki,Hiromichi Shirasu,Naoki Takahashi,Rie Nakatsuka,Takayuki Ando,Yosuke Kito,Yoshiyuki Yamamoto,Kentaro Kawakami,Toshihiko Matsumoto,Keitaro Shimozaki,Michitaka Nagase,Toshifumi Yamaguchi,Yuji Negoro,Takao Tamura,Yusuke Amanuma,Taito Esaki,Yuji Miura,Kengo Nagashima,Narikazu Boku

Hyperprogressive disease during nivolumab chemotherapy in metastatic gastric cancer: Multicenter retrospective study in Japan.

2020

377Background: Nivolumab has demonstrated a survival benefit for advanced gastric cancer (AGC). However, hyperprogressive disease (HPD) has been reported in various cancers. Methods: The subjects o...

Keywords:

Disease
Nivolumab
Internal medicine
Chemotherapy
Medicine
Oncology
Metastatic gastric cancer
Retrospective cohort study
Pathology
survival benefit
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations